105 related articles for article (PubMed ID: 31556147)
1. Both hypo- and hyperglycaemia are associated with increased fracture risk in Japanese people with type 2 diabetes: the Fukuoka Diabetes Registry.
Komorita Y; Iwase M; Fujii H; Ohkuma T; Ide H; Yoshinari M; Oku Y; Nakamura U; Kitazono T
Diabet Med; 2020 May; 37(5):838-847. PubMed ID: 31556147
[TBL] [Abstract][Full Text] [Related]
2. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
[TBL] [Abstract][Full Text] [Related]
3. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes.
Cooper MN; O'Connell SM; Davis EA; Jones TW
Diabetologia; 2013 Oct; 56(10):2164-70. PubMed ID: 23832082
[TBL] [Abstract][Full Text] [Related]
5. Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study.
Zabala A; Darsalia V; Holzmann MJ; Franzén S; Svensson AM; Eliasson B; Patrone C; Nyström T; Jonsson M
Diabetes Obes Metab; 2020 Feb; 22(2):182-190. PubMed ID: 31576643
[TBL] [Abstract][Full Text] [Related]
6. Polypharmacy and bone fracture risk in patients with type 2 diabetes: The Fukuoka Diabetes Registry.
Komorita Y; Ohkuma T; Iwase M; Fujii H; Oku Y; Higashi T; Oshiro A; Sakamoto W; Yoshinari M; Nakamura U; Kitazono T
Diabetes Res Clin Pract; 2021 Nov; 181():109097. PubMed ID: 34678390
[TBL] [Abstract][Full Text] [Related]
7. Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes: A randomized, placebo-controlled study.
Farngren J; Persson M; Ahrén B
Diabetes Obes Metab; 2018 Aug; 20(8):1911-1920. PubMed ID: 29645341
[TBL] [Abstract][Full Text] [Related]
8. Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study.
Lega IC; Campitelli MA; Austin PC; Na Y; Zahedi A; Leung F; Yu C; Bronskill SE; Rochon PA; Lipscombe LL
Diabetologia; 2021 May; 64(5):1093-1102. PubMed ID: 33491105
[TBL] [Abstract][Full Text] [Related]
9. Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12-month comparison by concomitant sulphonylurea and/or glinide use.
Terauchi Y; Riddle MC; Hirose T; Koyama M; Cheng X; Takahashi Y; Bolli GB
Diabetes Obes Metab; 2018 Nov; 20(11):2541-2550. PubMed ID: 29888454
[TBL] [Abstract][Full Text] [Related]
10. Glycemic control and fracture risk in elderly patients with diabetes.
Conway BN; Long DM; Figaro MK; May ME
Diabetes Res Clin Pract; 2016 May; 115():47-53. PubMed ID: 27242122
[TBL] [Abstract][Full Text] [Related]
11. Impact of Body Weight Loss From Maximum Weight on Fragility Bone Fractures in Japanese Patients With Type 2 Diabetes: The Fukuoka Diabetes Registry.
Komorita Y; Iwase M; Fujii H; Ohkuma T; Ide H; Jodai-Kitamura T; Sumi A; Yoshinari M; Nakamura U; Kang D; Kitazono T
Diabetes Care; 2018 May; 41(5):1061-1067. PubMed ID: 29540432
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study.
Davis TME; Bruce DG; Finn J; Curtis BH; Barraclough H; Davis WA
Diabetes Obes Metab; 2019 Mar; 21(3):648-657. PubMed ID: 30370611
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry.
Gitt AK; Bramlage P; Binz C; Krekler M; Plate T; Deeg E; Tschöpe D;
Eur J Prev Cardiol; 2012 Aug; 19(4):765-72. PubMed ID: 21628353
[TBL] [Abstract][Full Text] [Related]
14. Incidence of severe hypoglycemia and its association with serum adiponectin in Japanese patients with type 1 and insulin-treated type 2 diabetes: The Fukuoka Diabetes Registry.
Iwase M; Komorita Y; Fujii H; Ohkuma T; Ide H; Yoshinari M; Oku Y; Higashi T; Nakamura U; Kitazono T
J Diabetes Investig; 2020 Sep; 11(5):1258-1264. PubMed ID: 32180356
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study.
Home P; Calvi-Gries F; Blonde L; Pilorget V; Berlingieri J; Freemantle N
Diabetes Obes Metab; 2018 Apr; 20(4):921-929. PubMed ID: 29205734
[TBL] [Abstract][Full Text] [Related]
16. Increase in the incidence of severe hypoglycaemia in people with Type 2 diabetes in spite of new drugs: analysis based on health insurance data from Germany.
Müller N; Lehmann T; Gerste B; Adler JB; Kloos C; Hartmann M; Kramer G; Kuniss N; Müller UA
Diabet Med; 2017 Sep; 34(9):1212-1218. PubMed ID: 28586530
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with glycaemic control in adults with Type 1 diabetes: a registry-based analysis including 7601 individuals from 34 centres in Norway.
Cooper JG; Bakke Å; Dalen I; Carlsen S; Skeie S; Løvaas KF; Sandberg S; Thue G
Diabet Med; 2020 May; 37(5):828-837. PubMed ID: 31469928
[TBL] [Abstract][Full Text] [Related]
18. Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.
Owens DR; Bolli GB; Charbonnel B; Haak T; Landgraf W; Porcellati F; Traylor L; Kautzky-Willer A
Diabetes Obes Metab; 2017 Nov; 19(11):1546-1554. PubMed ID: 28449412
[TBL] [Abstract][Full Text] [Related]
19. Time in range following flash glucose monitoring: Relationship with glycaemic control, diabetes-related distress and resource utilisation in the Association of British Clinical Diabetologists national audit.
Deshmukh H; Wilmot E; Pieri B; Choudhary P; Shah N; Gregory R; Kilvert A; Lumb A; Christian P; Barnes D; Patmore J; Walton C; Ryder REJ; Sathyapalan T
Diabet Med; 2022 Nov; 39(11):e14942. PubMed ID: 36054655
[TBL] [Abstract][Full Text] [Related]
20. Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self-titrating insulin glargine U-100.
Hollander PA; Kiljanski J; Spaepen E; Harris CJ
Diabetes Obes Metab; 2019 Nov; 21(11):2413-2421. PubMed ID: 31264764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
